Skip to main content
Erschienen in: Gynecological Surgery 4/2013

01.11.2013 | Original Article

The effectiveness of outpatient Thermachoice endometrial balloon ablation: a long-term 11-year outcome study

verfasst von: Vinod Kumar, Janesh Kumar Gupta

Erschienen in: Gynecological Surgery | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the long-term treatment outcomes of outpatient Thermachoice balloon endometrial ablation under a direct local anaesthetic cervical block (LA-Thermachoice). This paper is a prospective cohort study and a postal questionnaire survey in a UK teaching hospital with the participation of 253 women with heavy menstrual bleeding (HMB) undergoing LA-Thermachoice over an 11-year period between 2001 and 2011. Treatment success was measured by postoperative bleeding patterns, improvement in dysmenorrhoea, patient satisfaction and post-procedure hysterectomy rates. LA-Thermachoice was completed in 98 % of women. The survey response rate was 78 %. The median follow-up interval was 71 months (SD 42). Seventy-nine percent of the responders reported significant improvement in HMB with 40 % amenorrhoea rate and 86 % improvement in dysmenorrhoea. Eighty-one percent felt that the benefit of procedure was maintained over a long period of time. Eighty-six percent of women were satisfied with the outcome of their procedure. The case notes of non-responders were examined to check if any had undergone hysterectomy since the LA-Thermachoice procedure. In total, only 16 % of women had a hysterectomy. This study represents the largest published series of local anaesthetic thermal endometrial ablation, reporting clinical outcomes with 11 years (median 71 months) of post-treatment follow-up. It demonstrates that the patient satisfaction with LA-Thermachoice is high, and is maintained over a long period of time after the procedure.
Literatur
1.
Zurück zum Zitat Sculpher MJ, Bryan S, Dwyer N, Hutton J, Stirrat GM (1993) An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 100:244–252PubMedCrossRef Sculpher MJ, Bryan S, Dwyer N, Hutton J, Stirrat GM (1993) An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 100:244–252PubMedCrossRef
2.
Zurück zum Zitat Shapley M, Jordan K, Croft PR (2004) An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54:359–363PubMed Shapley M, Jordan K, Croft PR (2004) An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54:359–363PubMed
3.
Zurück zum Zitat Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J (2013) Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 368:128–137PubMedCrossRef Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J (2013) Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 368:128–137PubMedCrossRef
4.
Zurück zum Zitat Cooper K, Lee A, Chien P, Raja E, Timmaraju V, Bhattacharya S (2011) Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG 118:1171–1179PubMedCrossRef Cooper K, Lee A, Chien P, Raja E, Timmaraju V, Bhattacharya S (2011) Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG 118:1171–1179PubMedCrossRef
5.
Zurück zum Zitat Pados G, Athanatos D, Tsolakidis D, Stamatopoulos P, Tarlatzis B (2011) Treatment options for dysfunctional uterine bleeding: evaluation of clinical results. GynecolSurg 8:385–393 Pados G, Athanatos D, Tsolakidis D, Stamatopoulos P, Tarlatzis B (2011) Treatment options for dysfunctional uterine bleeding: evaluation of clinical results. GynecolSurg 8:385–393
6.
Zurück zum Zitat Middleton LJ, Champaneria R, Daniels JP et al (2010) Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 341:c3929PubMedCrossRef Middleton LJ, Champaneria R, Daniels JP et al (2010) Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 341:c3929PubMedCrossRef
7.
Zurück zum Zitat Clark TJ, Samuels N, Malick S, Middleton L, Daniels J, Gupta J (2011) Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial. Obstet Gynecol 117:1228PubMedCrossRef Clark TJ, Samuels N, Malick S, Middleton L, Daniels J, Gupta J (2011) Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial. Obstet Gynecol 117:1228PubMedCrossRef
8.
Zurück zum Zitat Matteson KA, Abed H, Wheeler TL, Sung VW, Rahn DD, Schaffer JI, Balk EM (2012) A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding. J Minim Invasive Gynecol 19:13–28PubMedCrossRef Matteson KA, Abed H, Wheeler TL, Sung VW, Rahn DD, Schaffer JI, Balk EM (2012) A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding. J Minim Invasive Gynecol 19:13–28PubMedCrossRef
9.
Zurück zum Zitat Varma R, Soneja H, Samuel N, Sangha E, Clark TJ, Gupta JK (2010) Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures. Gynecol Obstet Invest 70:145–148PubMedCrossRef Varma R, Soneja H, Samuel N, Sangha E, Clark TJ, Gupta JK (2010) Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures. Gynecol Obstet Invest 70:145–148PubMedCrossRef
10.
Zurück zum Zitat Clark TJ, Gupta JK (2004) Outpatient thermal balloon ablation of the endometrium. Fertil Steril 82:1395–1401PubMedCrossRef Clark TJ, Gupta JK (2004) Outpatient thermal balloon ablation of the endometrium. Fertil Steril 82:1395–1401PubMedCrossRef
11.
Zurück zum Zitat Jarrell A, Olsen ME (2003) Patient satisfaction with thermal balloon endometrial ablation. A retrospective review. J Reprod Med 48:635–636PubMed Jarrell A, Olsen ME (2003) Patient satisfaction with thermal balloon endometrial ablation. A retrospective review. J Reprod Med 48:635–636PubMed
12.
Zurück zum Zitat Vilos GA, Fortin CA, Sanders B, Pendley L, Stabinsky SA (1997) Clinical trial of the uterine thermal balloon for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 4:559–565PubMedCrossRef Vilos GA, Fortin CA, Sanders B, Pendley L, Stabinsky SA (1997) Clinical trial of the uterine thermal balloon for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 4:559–565PubMedCrossRef
13.
Zurück zum Zitat Cash C Jr, Garza-Leal J, Donovan A et al (2012) Clinical evaluation of long-term safety and effectiveness of a third-generation thermal uterine balloon therapy system for heavy menstrual bleeding. J Minim Invasive Gynecol 19:469–476PubMedCrossRef Cash C Jr, Garza-Leal J, Donovan A et al (2012) Clinical evaluation of long-term safety and effectiveness of a third-generation thermal uterine balloon therapy system for heavy menstrual bleeding. J Minim Invasive Gynecol 19:469–476PubMedCrossRef
14.
Zurück zum Zitat Chapa HO, Antonetti AG, Venegas G, Sandate J, VanDuyne CP (2010) Menstrual and dysmenorrhea outcomes after ThermaChoice III: a 2-year prospective study. J Gynecol Surg 25:233–236CrossRef Chapa HO, Antonetti AG, Venegas G, Sandate J, VanDuyne CP (2010) Menstrual and dysmenorrhea outcomes after ThermaChoice III: a 2-year prospective study. J Gynecol Surg 25:233–236CrossRef
15.
Zurück zum Zitat Cooley S, Yuddandi V, Walsh T, Geary M, McKenna P (2005) The medium- and long-term outcome of endometrial ablative techniques. Eur J Obstet Gynecol Reprod Biol 121(2):233–5PubMedCrossRef Cooley S, Yuddandi V, Walsh T, Geary M, McKenna P (2005) The medium- and long-term outcome of endometrial ablative techniques. Eur J Obstet Gynecol Reprod Biol 121(2):233–5PubMedCrossRef
16.
Zurück zum Zitat Hazard D, Harkins G (2009) Patient satisfaction with thermal balloon ablation for treatment of menorrhagia. Am J Obstet Gynecol 200:e21–e23PubMedCrossRef Hazard D, Harkins G (2009) Patient satisfaction with thermal balloon ablation for treatment of menorrhagia. Am J Obstet Gynecol 200:e21–e23PubMedCrossRef
17.
Zurück zum Zitat Andersson S, Mints M (2007) Thermal balloon ablation for the treatment of menorrhagia in an outpatient setting. Acta Obstet Gynecol Scand 86:480–483PubMedCrossRef Andersson S, Mints M (2007) Thermal balloon ablation for the treatment of menorrhagia in an outpatient setting. Acta Obstet Gynecol Scand 86:480–483PubMedCrossRef
18.
Zurück zum Zitat Kleijn JH, Engels R, Bourdrez P, Mol BW, Bongers MY (2008) Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 115:193–198PubMedCrossRef Kleijn JH, Engels R, Bourdrez P, Mol BW, Bongers MY (2008) Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 115:193–198PubMedCrossRef
19.
Zurück zum Zitat Asch DA, Jedrziewski MK, Christakis NA (1997) Response rates to mail surveys published in medical journals. J Clin Epidemiol 50:1129–1136PubMedCrossRef Asch DA, Jedrziewski MK, Christakis NA (1997) Response rates to mail surveys published in medical journals. J Clin Epidemiol 50:1129–1136PubMedCrossRef
Metadaten
Titel
The effectiveness of outpatient Thermachoice endometrial balloon ablation: a long-term 11-year outcome study
verfasst von
Vinod Kumar
Janesh Kumar Gupta
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Gynecological Surgery / Ausgabe 4/2013
Print ISSN: 1613-2076
Elektronische ISSN: 1613-2084
DOI
https://doi.org/10.1007/s10397-013-0809-1

Weitere Artikel der Ausgabe 4/2013

Gynecological Surgery 4/2013 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.